Why the study?
Does the Actalyke analyzer with MaxACT tubes provide different ACT results and precision compared to the Hemochron 801 analyzer in patients requiring ACT testing?
Does the Actalyke analyzer with MaxACT tubes provide different ACT results and precision compared to the Hemochron 801 analyzer in patients requiring ACT testing?
Switching from the Hemochron 801 to the Actalyke-MaxACT system for ACT monitoring requires establishing new, system-specific therapeutic target ranges due to shorter clotting times and improved precision with the new system.
No takes yet. Share an insight, caveat, or question.
Requires new ACT range validation before Actalyke adoption; leaves open effects on clinical endpoints.
Toffaletti et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: